Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-09-15 Sale | 2023-09-18 4:26 pm | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer | 4,104 | $6.62 | $27,168 | 29,946 (Direct) | View |
| 2021-08-17 Sale | 2021-08-18 5:02 pm | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 2,896 | $33.78 | $97,814 | 87,320 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-18 Option Award | 2024-01-22 4:06 pm | N/A 2034-01-18 | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer | 320,650 | $0 | 350,596 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-15 6:18 pm | N/A 2033-05-12 | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika Chief Development Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2022-09-09 Option Award | 2022-09-13 4:26 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 34,050 | $0 | 34,050 (Direct) | View |
| 2022-02-10 Option Award | 2022-02-28 4:28 pm | N/A 2032-02-10 | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 68,100 | $0 | 68,100 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-18 5:02 pm | N/A N/A | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 2,896 | $3.53 | 87,320 (Direct) | View |
| 2021-08-17 Exercise | 2021-08-18 5:02 pm | N/A 2029-08-20 | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 2,896 | $0 | 87,320 (Direct) | View |
| 2021-05-12 Option Award | 2021-06-08 7:24 pm | N/A 2031-05-11 | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 22,674 | $0 | 22,674 (Direct) | View |
Ownership | 2020-09-24 7:11 pm | N/A 2029-08-20 | PMV Pharmaceuticals Inc. | PMVP | Jalota Deepika SVP, Regulatory Affairs and QA | 0 | $0 | 107,309 (Direct) | View |